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Abstract
Background: Definite diagnosis of malaria relies on microscopy detection of blood stages of parasites in peripheral
blood and requires blood sample collection. The nested PCR method has shown to be more sensitive and superior
to microscopy in detecting co-infections of Plasmodium species in circulation while Plasmodium falciparum DNA
can be identified in urine and saliva specimens of patients, albeit at a lower sensitivity.
Methods: Matched blood, saliva and urine samples were collected from 100 microscopy-positive and 20
microscopy-negative febrile patients who attended a malaria clinic in Tak Province, northwestern Thailand for
nested PCR analysis targeting the small subunit ribosomal RNA gene of human malaria. Both P. falciparum and
Plasmodium vivax have been known to circulate at a comparable rate in the study area.
Results: Comparing with microscopy results, nested PCR of saliva samples had a sensitivity of 74.1% for P.
falciparum detection and 84% for P. vivax detection while 44.4% and 34.0% of the corresponding values were
observed for urine samples. Both nested PCR results of saliva and urine samples had a specificity of 100% for
identification of P. falciparum and P. vivax when compared with nested PCR results from blood. Co-infections of
both species were found in four, 26 and 8 patients by microscopy and nested PCR of blood and saliva samples,
respectively. Although the positive rates of nested PCR of saliva samples for P. falciparum increased with parasite
density, no tendency occurred in results from nested PCR of saliva samples for P. vivax as well as those of urine
samples.
Conclusions: Saliva and urine samples could be alternative noninvasive sources of DNA for molecular detection of
both P. falciparum and P. vivax. Further improvement of the detection method will offer an opportunity to use
these samples for diagnosis of malaria.
Background
Plasmodium falciparum and Plasmodium vivax are the
main causative agents of human malaria accounting for
300-500 million cases and 130-145 million infections
per annum, respectively [1,2]. Definite diagnosis of acute
malaria infection in routine laboratory practice relies on
demonstration of asexual erythrocytic stages from
peripheral blood smears under light microscope.
Although the method is feasible, economical and practi-
cal, a number of symptomatic cases have been left
undiagnosed when parasitaemia did not reach the
microscopic detection threshold. Hence, a more sensi-
tive and specific PCR-based detection has been devel-
oped to amplify malarial DNA in patients’ blood
samples, unveiling a high prevalence of mixed species
malaria infections in some endemic areas [3-5]. Failure
to detect cryptic P. falciparum infections could lead to
the risk of developing severe or fatal outcomes while
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any medium, provided the original work is properly cited.missed vivax malaria may result in recurrent debilitating
infections and economic loss [3]. Nevertheless, repeated
examination of blood samples from malaria patients
during post-treatment follow-up may at times result in
poor compliance, especially among infants and young
children. Therefore, an alternative means for a noninva-
sive malaria diagnosis is required.
Recent studies have shown that P. falciparum DNA
could be detected in both urine and saliva samples of
infected individuals in Zambia by means of PCR amplifi-
cation of single copy genes encoding merozoite surface
protein-2 and dihydrofolate reductase [6]. The sensitivity
of PCR amplification of malarial DNA in these speci-
mens seems to rely on patient’s parasitaemia, DNA
extraction method and length of target amplicon. A sub-
sequent study in The Gambia has shown that detection
of the small subunit ribosomal RNA gene (SSU rRNA)
of P. falciparum in saliva and urine has high specificity
comparable to that obtained from blood samples
although the sensitivity of the method remains to be
improved for useful diagnostic purposes [7]. Likewise,
the sensitivity of PCR-based detection of the P. falci-
parum SSU rRNA gene using saliva samples reportedly
increased to 82% when considering only isolates with a
parasite density higher than or equal to 1,000 parasites/
ml, the parasite level that usually found in most malaria
patients in The Gambia and probably elsewhere [7].
Despite a lower sensitivity of PCR detection for P. falci-
parum from saliva and urine samples than that obtained
from blood-derived DNA template, repeated noninvasive
sample collections during drug trials or monitoring vac-
cine efficacy may be warranted [8].
Given that saliva and urine could be promising nonin-
vasive sources of P. falciparum DNA for PCR diagnosis,
it will be more beneficial when P. vivax DNA would
also exist in these specimens. To further validate the
potential roles of saliva and urine samples as the sources
of P. falciparum DNA for PCR-based detection in a
hypoendemic area outside Africa and to investigate the
possibility of P. vivax d e t e c t i o ni nt h e s es a m p l e s ,w e
performed a cross-sectional study in Thailand where
both Plasmodium species contribute ~99% of all malaria
cases [5,9,10].
Methods
Study area
This study was performed in a malaria clinic at Ta Song
Yang District in Tak Province, ~550 km northwest of
Bangkok, Thailand bordering Myanmar (GPS N17° 13’
36”,E 9 8 °1 3 ’ 30”). Ta Song Yang District occupies 355
km
2 with a population density of ~24 persons/km
2.
Most of the areas are mountainous and filled with for-
ests. In the rainy season, villagers would get into the
jungle for a long period to cut the bamboo shoots for
sale where they often return also with febrile malaria
attack. Annual malaria transmission in Thailand follows
a bimodal pattern, peaking in May-July and October-
November [10]. The number of malaria cases in this
country exhibits remarkable regional differences with
the highest annual parasite incidence (API) of ~15.5 in
Tak Province [9,10]. A comprehensive study of malaria
species in this community comprised an almost equal
distribution of P. falciparum and P. vivax while co-
infection of both species accounted for ~24% of all
malaria cases [5].
Patients and sample collection
A cross-sectional study was conducted during June and
July 2008. Inclusion criteria were febrile patients (oral
temperature > 37.5°C) of any age group seen at Ta Song
Yang malaria clinic who were willing to participate in
this study during May and June 2008. Exclusion criteria
were those having previous anti-malarial treatment or
presence of clinical signs and symptoms of severe
malaria [11]. In total, 100 malaria positive individuals
were recruited in which diagnosis was initially per-
formed by Giemsa-stained thick blood film at the
malaria clinic. In addition, 20 other subjects were
included who had febrile illness after entry and stay dur-
ing the past one month in the forest area where malaria
transmission was highly possible. Therefore, malaria
positive rate in this study does not reflect the actual pre-
valence in the study population. Approximately 2 ml of
venous blood were drawn from each subject after
informed consent. Blood samples were preserved using
EDTA as an anticoagulant and kept on ice during trans-
portation from the study site to our laboratory at Chula-
longkorn University where samples were subsequently
stored at -40°C until use. Collection of urine and saliva
samples was done immediately after blood sample col-
lection and prior to anti-malarial treatment. Approxi-
mately 1 - 2 ml of saliva sample and 20 ml of
midstream urine were obtained from each case. Half
volume of these samples was kept on ice during trans-
portation to the laboratory while the remaining part was
preserved by adding ~two volumes of absolute ethanol
and kept at ambient temperature (25°C - 35°C) until
DNA extraction.
Microscopy
Both thin and thick blood smears were prepared for
each isolate and stained with 10% Giemsa solution. The
thin blood film was examined for at least 200 micro-
scopic fields and the thick blood film for at least 200
leukocytes, using a 100× objective. The microscopist
who has more than 20 years of experience in identifica-
tion of malaria and other human parasites was blinded
to any clinical diagnosis, onsite microscopy-based
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study. The parasite density was estimated by assuming a
leukocyte count of 7,000/ml [12].
DNA extraction
DNA of each isolate was extracted from 200 ml of
blood, saliva and urine samples using Qiagen DNA Mini
Kit. DNA was purified following the manufacturer’s
recommendation.
PCR-based detection
Detection of P. falciparum and P. vivax was done by
nested PCR amplification protocol as described by Puta-
porntip et al [5]. Briefly, 2 ml of DNA was added to a total
volume of 20 ml amplification reaction mixture with Plas-
modium genus-specific outer primers derived from the
SSU rRNA gene (M18SF0: 5’-CCATTAATCAAGAAC-
GAAAGTTAAGG-3’ and M18SR0: 5’-CAAGGAAGTT-
TAAGGCAACAACA-3’) for primary PCR. Thirty-five
cycles (94°C for 40 s, 60°C for 30 s and 72°C for 1 min)
were performed. One ml of PCR product from primary
PCR was used as DNA template for secondary PCR in
which amplification for P. falciparum and P. vivax was
done in separate reaction tubes. The amplification reaction
and thermal cycling profile for secondary PCR were essen-
tially as those for primary PCR except that respective pair
of the species-specific inner primers (P. falciparum,
PF18SF: 5’-CATCTTTCGAGGTGACTTTTAG-3’ and
PF18SR: 5’-GTTTTTTACTCTATTTCTCTCTTC-3’;
P. vivax,P V 1 8 S F :5 ’-GAATTTTCTCTTCGGAGTTTA
TTC-3’ and PV18SR: 5’-TAACAGTTTCCCTTTCCC
TTTTCTAC-3’; P. malariae, PM18SF: 5’-GAGACATT
CATATATATGAGTG-3’ and PM18SR: 5’-GTTT
TTTTTAATAAAAACGTTCTTTTCCC-3’; P. ovale,
PO18SF: 5’-GAAAAFFCCTTTTGGAAATTTCTTAG-3’
and PO18SR: 5’-GATACATTATAGTGTCCTTTTCCC-
3’ and P. knowlesi, PK18SF: 5’-GAGTTTTTCTTTT
CTCTCCGGAG-3’ and PK18SR: 5’-ACGTTAAATGT-
GATTCCTTTCCC-3’) and 25 cycles were used. The PCR
products were separated in 1% and 2% agarose gels for pri-
mary and nested PCR, respectively. After staining with
ethidium bromide, the gel was visualized under a UV light.
The PCR amplified fragments of the SSU rRNA gene of
P. falciparum and of P. vivax were 452 bp and 419 bp,
respectively.
Data analysis
Diagnostic performance for each test was evaluated with
the results from nested PCR assay of DNA extracted
from blood samples as the gold standard. Performance
indices were the number of true positive (TP), number
of true negative (TN), number of false positive (FP) and
number of false negative (FN). Sensitivity was expressed
as TP/(TP+FN) and specificity as TN/(TP+FP).
Accuracy of the tests were calculated as (TP/TN)/num-
ber of all tests. Kappa statistics was used to compare
the agreement against which might be expected by
chance with possible values range from range from +1
(perfect agreement) via 0 (no agreement above that
expected by chance) to -1 (complete disagreement) [13].
Ethics
The ethical aspects of this study have been approved by
the Institutional Review Board of Faculty of Medicine,
Chulalongkorn University.
Results
Of 120 febrile individuals participated in this study, 73
(60.8%) were males and 47 (39.2%) were females. The
age range was 4 to 60 years old (mean = 20.3 years;
median = 15.5 years). The majority of these subjects
(82.5%) had experienced one or more episodes of pre-
vious malaria attack but not during the past one month
prior to sample collection. Patients with microscopy
positive for asexual blood stages of malaria had body
temperature from 38°C to 41°C and none had overt
severe manifestations.
Microscopic examination of blood films by the experi-
enced microscopist has detected malaria parasites in 100
patients, which was in good agreement with the results
obtained from microscopy detection by a local staff at
the malaria clinic. Of these, perfect agreement was
observed for single infection of P. falciparum in 50
patients and P. vivax in 46 patients while co-infections
of both species were observed in four isolates by the
experienced microscopist but not by the local malaria
clinic staff. The overall parasite density of microscopy
positive samples ranged from 35 to 311,395 parasites/ml
(geometric mean = 13,920 parasites/ml). Isolates con-
taining single infection of P. falciparum as determined
by nested PCR had parasite density ranged from 35 to
217,805 parasites/ml (geometric mean = 2,761 parasites/
ml) while that of P. vivax was between 35 to 44,520
parasites/ml (geometric mean = 1,248 parasites/ml).
The nested PCR method using DNA templates from
blood samples has detected 106 febrile patients infected
with P. falciparum (n = 43), P. vivax (n = 37) and co-
infection of both species (n = 26). None gave positive
tests for Plasmodium malariae, Plasmodium ovale and
Plasmodium knowlesi-specific PCR primers. All 100
patients harboring malaria parasites in their blood
smears gave positive results for PCR assay while six
patients whose blood smears were negative by micro-
scopy were positive for P. falciparum (n = 2), P. vivax
(n = 1) and mixed infection of both species (n = 3) by
PCR method (Table 1).
The nested PCR assay has detected malaria SSU rRNA
g e n ef r a g m e n t si n4 3o f1 2 0s a l i v as a m p l e st h a tw e r e
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of saliva samples in ethanol has increased more than
twice the yield of positive results as 76 samples gave
positive tests. Thirty-nine saliva samples preserved in
ethanol gave positive results while the same samples
k e p to ni c ew e r en e g a t i v ea n dt h eo p p o s i t ew a st r u ei n
nine isolates. In total, 85 saliva samples were positive by
nested PCR method. Likewise, unpreserved urine sam-
ples showed a lower positive rate than those preserved
in ethanol, i.e. 18 and 30 positives, respectively.
Identification of malaria species by microscopy and
nested PCR of blood, saliva and urine is shown in Table
1. Consistent with our previous study, co-infection of
both P. falciparum and P. vivax accounted for 26% of
all malaria positive cases from northwest Thailand as
detected by nested PCR of blood [5]. Interestingly,
nested PCR assay using saliva samples outperformed
microscopy in detection of mixed species infection
(Table 1). None of the isolates that were negative by
PCR test using DNA template from blood (n = 14) gave
Table 1 Microscopy diagnosis and nested PCR detection of Plasmodium falciparum and P. vivax in blood, saliva and
urine samples.
Method Specimen
(n = 120)
Result Nested PCR (blood) Total
P. falciparum P. vivax P. falciparum +
P. vivax
Negative
Microscopy Blood P. falciparum 41 0 9 0 50
P. vivax 03 6 1 0 0 4 6
P. falciparum+ P. vivax 00 4 0 4
Negative 2 1 3 14 20
Nested PCR Saliva (in ethanol) P. falciparum 27 0 5 0 32
P. vivax 03 2 5 0 3 7
P. falciparum+ P. vivax 00 7 0 7
Negative 16 5 9 14 44
Saliva (on ice) P. falciparum 18 0 5 0 23
P. vivax 01 2 5 0 1 7
P. falciparum+ P. vivax 00 3 0 3
Negative 25 25 13 14 77
Saliva (all)* P. falciparum 31 0 6 0 37
P. vivax 03 2 8 0 4 0
P. falciparum+ P. vivax 00 8 0 8
Negative 12 5 4 14 35
Urine (in ethanol) P. falciparum 16 0 4 0 20
P. vivax 08 2 0 1 0
P. falciparum+ P. vivax 00 0 0 0
Negative 27 29 20 14 90
Urine (on ice) P. falciparum 80 2 0 1 0
P. vivax 06 2 0 8
P. falciparum+ P. vivax 00 0 0 0
Negative 35 31 22 14 102
Urine (all)* P. falciparum 19 0 6 0 25
P. vivax 01 3 4 0 1 7
P. falciparum+ P. vivax 00 0 0 0
Negative 24 24 16 14 78
Total 43 37 26 14 120
* Positives from samples either kept on ice or preserved in ethanol.
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and urine samples.
When P. falciparum and P. vivax were considered
separately, nested PCR assay displayed more sensitivity
of detection using DNA templates extracted from etha-
nol preserved saliva and urine samples than the unpre-
served corresponding ones (Table 2). Evaluation of
diagnostic performance using results from nested PCR
of blood as gold standard has shown that sensitivity of
microscopy for P. falciparum detection was 78.3% and
P. vivax 79.4%. PCR assays of ethanol-preserved saliva
and urine specimens uniformly outperformed those kept
on ice. In total, the sensitivity of combined results from
saliva samples kept on ice and ethanol preserved ones
was 65.2% for P. falciparum and 69.8% for P. vivax.
Likewise, the sensitivity of combined results from urine
samples preserved on ice and ethanol preserved ones
was 36.2% and 27.0% for P. falciparum and P. vivax,
respectively. It is noteworthy that combined PCR results
of saliva kept on ice and those preserved in ethanol
exhibited slightly lower accuracy and kappa values for P.
falciparum and P. vivax than results from microscopy
(Table 2).
Using results from microscopy as reference, nested
PCR assay of blood detected malaria in all microscopy
positive samples and, additionally, P. falciparum in
22.7% and P. vivax in 18.6% of microscopy-negatives.
PCR assay of saliva samples identified P. falciparum in
74.1% and P. vivax in 84.0% of microscopy-positives
while five and six samples diagnosed to be negative by
microscopy contained P. falciparum and P. vivax in
their respective saliva samples. Meanwhile, 44.4% and
34.0% of microscopy positive isolates possessed P. falci-
parum and P. vivax DNA in their urine. In addition,
one microscopy negative isolate was positive for P. falci-
parum in urine specimen (Table 3). Although the posi-
tive rates of nested PCR for P. falciparum detection in
saliva exhibited some tendency toward increasing para-
site density (r = 0.797, df = 3, p = 0.055), other tests did
not show a similar trend (r = 0.459 - 0.745, p = 0.074 -
0.541) (Table 4).
Discussion
Over the past decades, alternative tests for malaria diag-
nosis have been developed in order to increase the diag-
n o s t i cp e r f o r m a n c eo fm i c r o s c o p yb ys p e c i e s - s p e c i f i c
PCR method, and to facilitate diagnosis by the advent of
rapid diagnostic tests so that electricity and well-trained
personnel are not required [14]. However, the pre-requi-
site for all these tests depends on blood samples con-
taining parasite materials. Recent studies have shown
that DNA of P. falciparum can be demonstrated in sal-
iva and urine samples of infected individuals paving a
novel alternative source of specimens for potential
malaria diagnosis. Evaluation of PCR-based detection of
P. falciparum in Gambian patients using saliva and
urine samples compared with microscopy has revealed a
high specificity (97%-98%) while its sensitivity remains
moderate to low (73% for saliva and 32% for urine sam-
ples) [7].
R e s u l t sf r o mt h i ss t u d yhave reaffirmed that P. falci-
parum DNA could be identified in both saliva and urine
samples of infected individuals in Tak Province. PCR
assays of saliva and urine samples comparing with
Table 2 Diagnostic performance of microscopy and nested PCR assays using DNA templates from saliva and urine
samples.
Method/Specimen Category % Sensitivity % Specificity Accuracy Kappa
Microscopy P. falciparum 78.3 100 87.5 0.75
P. vivax 79.4 100 89.2 0.79
Nested PCR
Saliva (in ethanol) P. falciparum 56.5 100 75.0 0.53
P. vivax 69.8 100 84.2 0.69
Saliva (on ice) P. falciparum 37.7 100 64.2 0.34
P. vivax 31.8 100 64.2 0.31
Saliva (all) P. falciparum 65.2 100 80.0 0.61
P. vivax 76.2 100 87.5 0.75
Urine (in ethanol) P. falciparum 29.0 100 59.2 0.26
P. vivax 15.9 100 55.8 0.15
Urine (on ice) P. falciparum 14.5 100 50.8 0.13
P. vivax 12.7 100 54.2 0.12
Urine (all) P. falciparum 36.2 100 63.3 0.33
P. vivax 27.0 100 61.7 0.26
Note. Nested PCR results from blood samples are used as the reference standard.
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44.4%, respectively, which are in good agreement with
previous study by others using samples from patients in
T h eG a m b i aw h e r em a l a r i at r a n s m i s s i o ni sm u c hm o r e
intense than in Thailand [7]. It is, therefore, likely that
excretion or transport of malarial DNA from circulation
to saliva and urine occur similarly between these popu-
lations during the course of infection. Importantly, this
study demonstrated for the first time that P. vivax can
also be detected in both saliva and urine samples of
patients at a comparable diagnostic performance for P.
falciparum.F u r t h e r m o r e ,c o - i n f e c t i o no fP. falciparum
and P. vivax could be concordantly diagnosed in saliva
and blood samples in 8 patients or 30.8% of mixed
infections identified by PCR from blood samples.
Proper preservation of clinical specimens from the
field to well-equipped laboratory is a key factor influen-
cing the performance of the tests. Because malaria is
endemic in tropical countries, trace amount of bacterial
or other microorganism contaminants in urine and sal-
iva samples could interfere with subsequent malarial
DNA extraction. This study has shown that saliva and
urine samples preserved in ethanol yielded positive
results by nested PCR method superior to those kept on
ice without preservation; thereby the less efficiency of
PCR performance for samples kept on ice could reflect
a remarkable loss of malarial DNA after prolonged sto-
rage without ethanol preservation. It seems likely that
malarial DNA recovered from ethanol preserved saliva
and urine samples in this study gave comparable PCR
positive rate to those freshly collected from patients in
Table 3 Comparison of nested PCR assays using blood, saliva and urine samples with microscopy results as reference.
Microscopy (%)
Nested PCR P. falciparum P. vivax
Positive (n = 54) Negative (n = 66) Positive (n = 50) Negative (n = 70)
Blood
Positive 54 (100) 15 (22.7) 50 (100) 13 (18.6)
Negative 0 51 (77.3) 0 57 (81.4)
Saliva (in ethanol)
Positive 35 (64.8) 4 (6.1) 40 (80.0) 4 (5.7)
Negative 19 (35.2) 62 (93.9) 10 (20.0) 66 (94.3)
Saliva (on ice)
Positive 24 (44.4) 2 (3.0) 18 (36.0) 2 (2.9)
Negative 30 (55.6) 64 (97.0) 32 (64.0) 68 (97.1)
Saliva (all)
Positive 40 (74.1) 5 (7.6) 42 (84.0) 6 (8.6)
Negative 14 (25.9) 61 (92.4) 8 (16.0) 64 (91.4)
Urine (in ethanol)
Positive 20 (37.0) 0 10 (20.0) 0
Negative 34 (63.0) 66 (100) 40 (80.0) 70 (100)
Urine (on ice)
Positive 9 (16.7) 1 (1.5) 8 (16.0) 0
Negative 45 (83.3) 65 (98.5) 42 (84.0) 70 (100)
Urine (all)
Positive 24 (44.4) 1 (1.5) 17 (34.0) 0
Negative 30 (55.6) 65 (98.5) 33 (66.0) 70 (100)
Table 4 Relationship between parasite density and
positive tests by nested PCR of saliva and urine samples
from malaria patients with single infections.
Specimen Parasites/μl No. positives/Total positives by
blood PCR (%)
P. falciparum P. vivax
Saliva
<1,000 5/7 (71.4) 2/3 (66.7)
>1,000 25/34 (73.5) 30/33 (90.9)
>5,000 23/27 (85.2) 15/16 (93.8)
>10,000 18/19 (94.7) 11/12 (91.7)
>50,000 8/8 (100) -
Urine
<1,000 2/7 (28.6) 0/3 (0)
>1,000 17/34 (50.0) 13/33 (39.4)
>5,000 11/27 (37.0) 6/16 (37.5)
>10,000 10/19 (52.6) 4/12 (33.3)
>50,000 5/8 (62.5) -
Note: Co-existence of both malaria species in three isolates was excluded
from analysis.
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suitable for sample collection in field study.
The amount of P. falciparum DNA detected in urine
and saliva samples has reportedly been ~2500-fold and
~600-fold less than that in blood concurrently obtained
from infected individuals, a crucial issue that potentially
compromises their diagnostic performance [7]. It is
interesting to note that the sensitivity of PCR-based
detection for P. falciparum in saliva comparing with
microscopy of malaria patients in The Gambia seems to
increase in samples with parasite density greater or
equal to 1000 parasites/ml [7]. This study has shown
that the positive rates of nested PCR for P. falciparum
detection in saliva samples increased in isolates with
high parasite density and such correlation was
approaching significant level. On the other hand, no
such trends were observed in urine samples for P. falci-
parum and both saliva and urine samples for P. vivax,
suggesting that the presence of malarial DNA in urine
and saliva may not directly correlate with concurrent
parasite density in circulation. Further study is required
to elucidate how malarial DNA is transported to saliva
and urine of malaria patients. Nevertheless, improve-
ment of detection method is of primary importance
before saliva and urine samples can be reliably applied
for alternative diagnosis of malaria parasites or evalua-
tion of malaria control measures such as vaccine
efficacy.
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